№ files_lp_4_process_3_126743
File format: docx
Character count: 2448
File size: 16 KB
Comparative scientific study analyzing blood alcohol concentrations in myocardial infarction patients in Tripoli hospitals using both traditional enzymatic and HS-GC/FID techniques.
Year:
2026
Region / City:
Tripoli, Libya
Subject:
Blood alcohol analysis in myocardial infarction patients
Document type:
Comparative research study
Institution / Organization:
Judicial Expertise and Research Center / Ministry of Justice; Faculty of Pharmacy, University of Tripoli
Authors:
Mohammed S. ALrheem, Doaa A. Mansour, Asma O. Jebril
Target audience:
Forensic and medical professionals
Sample size:
48 individuals, including MI patients and healthy controls
Methods:
Head space-gas chromatography/flame ionization detector (HS-GC/FID) and Lactate dehydrogenase (LDH) enzymatic technique
Statistical analysis:
IBM SPSS Version 21, descriptive analysis, Mann-Whitney U test, Pearson correlation
Key findings:
LDH method shows significant differences in BAC between healthy and MI patients, HS-GC/FID method shows no significant differences; correlation between LDH levels and BAC concentration R² = 0.76
Recommendations:
Larger sample sizes for future studies and preference for more accurate techniques in forensic analysis
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Project title:
Stabilization to Recovery Transition (START) in Libya
Project number:
00119794
Implementing partner:
UNDP
Start date:
March 2020
End date:
February 2021
Geographic scope:
West, East and South Libya
Thematic areas:
stabilization, early recovery, resilience, peacebuilding, humanitarian-development-peace nexus
Target groups:
local governments, women, youth, migrants, internally displaced persons, host communities
Related programmes:
Strengthening Local Capacities for Resilience and Recovery (SLCRR); Stabilization Facility for Libya (SFL)
Contributing framework:
UNDAF
Total budget:
USD 2,727,272
Donor:
Government of Japan
Gender marker:
2
Type of document:
programme and project summary
Date:
18 March 2017
Place:
Cairo
City of meeting:
Cairo
Country:
Egypt
Type of document:
Joint communiqué
Subject:
Political situation in Libya
Organizations involved:
League of Arab States; African Union; European Union; United Nations
Framework referenced:
Libyan Political Agreement (LPA)
Participating representatives:
Secretary General of the League of Arab States; AU High Representative for Libya; EU High Representative for Foreign Affairs and Security Policy; Special Representative of the UN Secretary-General for Libya
Geographical focus:
Libya
Key issues:
Political process; security situation; oil infrastructure; counter-terrorism; border security; democratic transition
Related events:
Armed attacks in the Oil Crescent beginning 3 March 2017; ceasefire declared on 15 March 2017
International mechanisms referenced:
UN Security Council resolutions; AU High Level Committee on Libya; Neighboring States Mechanism
Year:
2016
Region / City:
Global
Subject:
International relations, Humanitarian intervention
Document type:
Article
Organization:
University of Law, Leeds Campus, Teesside University, Centre for Syrian Studies, University of St. Andrews
Author:
Danny Singh, Haian Dukhan
Target audience:
Scholars, policymakers, students in political science and international relations
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2023
Region:
MENA
Office:
Libya Country Office
Evaluation Type:
Evaluability Assessment
Person-In-Charge:
Mohammad Fayyazi
Allowed Editor:
Elijah Asadhi
Planned Completion Dates:
31.05.2024, 31.08.2024, 31.06.2024, 31.12.2024
Key Topics:
Programme Management, Monitoring and Evaluation, Climate Change Integration, Gender Equality, Youth Engagement
Action Status:
Completed, Underway, Cancelled
Responsible Offices:
Deputy Representative’s Office, PME
Responsible Persons:
Marie-Consolee Mukangendo, Elijah Asadhi
Document Type:
Management Response
Year:
2020
Region / city:
Australia / New Zealand
Topic:
Food Standards Assessment
Document Type:
Technical Assessment Report
Agency:
Food Standards Australia New Zealand (FSANZ)
Author:
FSANZ
Target Audience:
Regulatory Authorities, Food Safety Experts
Period of validity:
Ongoing
Approval Date:
14 May 2020
Date of changes:
None
Contextual Description:
This document provides a technical and risk assessment report regarding the approval process for the enzymatic production of rebaudioside E, a steviol glycoside, derived from stevia leaf extract for use as a food additive in Australia and New Zealand.
Year:
2019
Region / City:
Tianjin, China
Subject:
Enzymatic Synthesis, Biocatalysis
Document Type:
Research Article
Organization / Institution:
National Technology Innovation Center of Synthetic Biology, Tianjin Institute of Industrial Biotechnology, Tianjin University of Science & Technology
Authors:
Yunfeng Cui, Yangyang Ji, Xi Chen, Jianjiong Li, Jinhui Feng, Qing Zhao, Peiyuan Yao, Qiaqing Wu, Dunming Zhu
Target Audience:
Researchers in the field of synthetic biology, biocatalysis, and enzymology
Period of Action:
N/A
Approval Date:
N/A
Date of Amendments:
N/A
Year:
2018
Region / city:
Alfred, NY
Subject:
Biology, Biochemistry
Document type:
Research article
Organization / institution:
Alfred University, Department of Biology
Author:
Geoffrey Lippa
Target audience:
Students in biological sciences
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Year:
Not specified
Country:
United States
Institution:
Arcus Biosciences, Inc.
Location:
Hayward, California
Document Type:
Scientific methodological supplement
Research Field:
Cancer immunotherapy; molecular and cellular biology
Subject:
Experimental characterization of the anti-CD39 antibody AB598
Author:
Amy E. Anderson; Kaustubh Parashar; Ke Jin; Julie Clor; Carlo E. Stagnaro; Urvi Vani; Jaskirat Singh; Ada Chen; Yihong Guan; Priyanka Talukdar; Pavithra Sathishkumar; Damie J. Juat; Hema Singh; Ritu Kushwaha; Xiaoning Zhao; Angelo Kaplan; Lisa Seitz; Matthew J. Walters; Ester Fernandez-Salas; Nigel P. C. Walker; Christine E. Bowman
Corresponding Author:
Christine E. Bowman
Organization Address:
Arcus Biosciences Inc., 3928 Point Eden Way, Hayward, CA 94545
Contact Email:
[email protected]
Contact Phone:
510-694-6200
Biological Target:
CD39 (ENTPD1)
Experimental Techniques:
Surface plasmon resonance (SPR); flow cytometry; luminescence assays; CRISPR knockout; qPCR; western blot
Biological Materials:
Human monocytes; PBMCs; B cells; SK-MEL-5 cells; MOLP8 cells; whole blood from healthy donors
Study Focus:
Binding kinetics, enzymatic inhibition, ATP hydrolysis, and CD39 surface expression following exposure to AB598